Loading
Latest filing published 21 Aug 2026 for Pentixapharm Holding AG. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Eckert Wagniskapital und Frühphasenfinanzierung GmbH in Pentixapharm Holding AG. Between 11 September 2025 and 30 July 2026, the trades on record add up to 7 filings.
No open-market sale appears; the market trades are 5 purchases worth €626k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
A typical purchase (the median) is worth €99k. No cluster: in 4 purchases, no other insider of the company bought within 30 days.
The record was last updated on 21 August 2026 with a transaction in Pentixapharm Holding AG. The most recent open-market purchase was published on 27 November 2025, 325 days ago. Between a trade and the moment it shows up on BaFin, the median delay is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by BaFin. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations